The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score -18.99 — distress zone — historically elevated failure riskWatch
- Earnings-manipulation signal · Beneish M -0.86 — flag raised, worth a closer lookWatch
- Earnings quality 61/100 — worth a closer lookWatch
Where the revenue comes from
Fiscal 2025, as SANUWAVE Health, Inc. reports it. History and quarterly detail are in the app.
- Consumables, parts, and accessories revenue$25.8M
- System revenue$17.8M
- Other$206K
- Extended warranty$172K
- License fees$20K
Leadership changes
From SANUWAVE Health, Inc.'s own filings, the day they're filed.
- Andrew Walko · President · departureeff. 2025-10-24
- Andrew Walko · President · departureeff. 2025-10-24
- Daniel Coyle · Chief Operating Officer · appointmenteff. 2025-09-25
Latest filings
- 8-K · Company announcement2026-06-16
- 8-K · Company announcement2026-06-15
- 10-Q · Quarterly report2026-05-12
- 8-K · Company announcement2026-05-12
- DEF 14A · Annual proxy (pay & governance)2026-04-29
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, every figure source-linked🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask anything about SANUWAVE Health, Inc., every answer cited🔒
- The Intelligence Brief — added when SANUWAVE Health, Inc.'s brief passes our SEC-figure check🔒
Every figure links to the filing it came from, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.